FDA Drugs (New Approvals & NDA)Original article
Thomas Brunner Hygiene GmbH - 729018 - 07/24/2026
RegulatoryNegative
AI Analysis
Summary
Thomas Brunner Hygiene GmbH received an FDA enforcement action for CGMP violations and manufacturing/distribution of unapproved, misbranded, and adulterated pharmaceutical products.
Outcome Details
CGMP violation, unapproved new drug, misbranded and adulterated products
Importance:4/10
Sentiment:
-0.80
FDAregulatoryCGMPcomplianceenforcementunapproved drugmisbrandingadulteration
Read the original article
Published by FDA Drugs (New Approvals & NDA) on August 5, 2026 7:34 PM